Table 2.

Tumor cytogenetics and major copy number amplifications.

Tumor #	Cytogenetics	BCR/TCR-based tumor type	Oncogene amplifications	Tumor suppressor deletions	Fragile site gene CNA	MLL rearrangement partners amplified
MPr14-111	40,XX	CLP-like		Ebf1, Cdkn2a		Lpp
MPr14-143	40,XX	Precursor-B	Eg5
MPr14-185	43,XY,+14,+15,+17	Precursor-B	Eg5, Tbx2	Cdkn2a		Mllt10
MPr14-189	40,XY,del(18qD1→qter), del(19qter→qB)	Precursor-B	Tbx2			Mllt10, Ell, Mllt3
MPr14-217	40,XY	Precursor-B	Notch1, Tcf3, Tbx2	Ebf1	Grid2
MPr14-218	41,XY,+1	Precursor-B		Ebf1	Wwox	Ell
MPr14-148	40,XX	Precursor-T	Eg5
MPr14-258	40,XX	Precursor-T	Eg5			Ell, Eps15, Lpp
MPr14-147	42,XX,+14,+15	Mixed	Eg5	Pax5	Grid2	Mllt10
MPr14-197	40,XY	Mixed	Mycl1, Eg5, Tbx2	Cdkn2a, Fhit	Fhit	Mllt10, Lpp
MPr14-228	41,XY,+2	Mixed	Lmo1	Ikzf1	Wwox	Mllt10, Ell, Lpp
MPr14-196	40,XY	Unclassified	Lmo1, Eg5	Cdkn2a